Literature DB >> 22987061

New and unconventional treatments for obstructive sleep apnea.

Jose Angelo A De Dios1, Steven D Brass.   

Abstract

Although continuous positive airway pressure, oral appliances and surgical modifications of the airway are considered as part of the routine management of patients with obstructive sleep apnea, many new and unconventional therapies exist. Many of the trials using these new alternatives have been limited by insufficient data, poor trial design, small sample size, unclear inclusion criteria, lack of randomization, and lack of blinding, and on occasion are biased by retrospective design. Bariatric surgery, positional therapy, auto-titrating positive airway pressure, serotonin agents, wake promoting agents, genioglossus stimulation surgery, supplemental oxygen, nasal dilators, nasal expiratory resistor devices and oropharyngeal exercises will be reviewed. As obstructive sleep apnea impacts the individual and society at large, further research is needed to explore new therapeutic treatment options for obstructive sleep apnea. Therapeutic trials for obstructive sleep apnea must be of rigorous design to prove clinical effectiveness while taking into account both patient satisfaction and cost effectiveness.

Entities:  

Mesh:

Year:  2012        PMID: 22987061      PMCID: PMC3480568          DOI: 10.1007/s13311-012-0146-5

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  42 in total

1.  Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea.

Authors:  Amit V Patel; Dennis Hwang; Maria J Masdeu; Guo-Ming Chen; David M Rapoport; Indu Ayappa
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

2.  Comparison of positional therapy to CPAP in patients with positional obstructive sleep apnea.

Authors:  Irene Permut; Montserrat Diaz-Abad; Wissam Chatila; Joseph Crocetti; John P Gaughan; Gilbert E D'Alonzo; Samuel L Krachman
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

3.  Effect of nasal-valve dilation on obstructive sleep apnea.

Authors:  B Schönhofer; K A Franklin; H Brünig; H Wehde; D Köhler
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

Review 4.  Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.

Authors:  C McDaid; S Griffin; H Weatherly; K Durée; M van der Burgt; S van Hout; J Akers; R J O Davies; M Sculpher; M Westwood
Journal:  Health Technol Assess       Date:  2009-01       Impact factor: 4.014

5.  Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea.

Authors:  Nathaniel S Marshall; Brendon J Yee; Anup V Desai; Peter R Buchanan; Keith K H Wong; Renee Crompton; Kerri L Melehan; Nadene Zack; Srinivas G Rao; R Michael Gendreau; Jay Kranzler; Ronald R Grunstein
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

6.  Response of obstructive sleep apnea to fluoxetine and protriptyline.

Authors:  D A Hanzel; N G Proia; D W Hudgel
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

7.  Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders.

Authors:  Clete A Kushida; Michael R Littner; Max Hirshkowitz; Timothy I Morgenthaler; Cathy A Alessi; Dennis Bailey; Brian Boehlecke; Terry M Brown; Jack Coleman; Leah Friedman; Sheldon Kapen; Vishesh K Kapur; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer; Todd J Swick; Merrill S Wise
Journal:  Sleep       Date:  2006-03       Impact factor: 5.849

8.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning.

Authors:  Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

9.  Anti-Obesity Drugs: A Review about Their Effects and Safety.

Authors:  Jun Goo Kang; Cheol-Young Park
Journal:  Diabetes Metab J       Date:  2012-02-17       Impact factor: 5.376

10.  Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.

Authors:  Thomas Roth; Gregory A Rippon; Sanjay Arora
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

View more
  6 in total

1.  Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea-Hypopnea Syndrome: Factors Associated with Postoperative Efficacy.

Authors:  Xiao Jiao; Jianyin Zou; Pin Zhang; Haoyong Yu; Jianzhong Di; Xiaodong Han; Shankai Yin; Hongliang Yi
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

2.  The treatment of sleep disorders.

Authors:  Rafael Pelayo; Emmanuel Mignot
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

Review 3.  Myofunctional Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis.

Authors:  Macario Camacho; Victor Certal; Jose Abdullatif; Soroush Zaghi; Chad M Ruoff; Robson Capasso; Clete A Kushida
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

Review 4.  Non-surgical treatment of obstructive sleep apnea syndrome.

Authors:  Xu Tingting; You Danming; Chen Xin
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-24       Impact factor: 2.503

Review 5.  A review of EPAP nasal device therapy for obstructive sleep apnea syndrome.

Authors:  Hao Wu; Xiandao Yuan; Xiaojun Zhan; Li Li; Yongxiang Wei
Journal:  Sleep Breath       Date:  2014-09-23       Impact factor: 2.816

6.  Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea in a Chinese Population with Obesity and T2DM.

Authors:  Jianyin Zou; Pin Zhang; Haoyong Yu; Jianzhong Di; Xiaodong Han; Shankai Yin; Hongliang Yi
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.